Express Scripts's most recent trend suggests a bullish bias. One trading opportunity on Express Scripts is a Bull Put Spread using a strike $60.00 short put and a strike $55.00 long put offers a potential 6.16% return on risk over the next 25 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $60.00 by expiration. The full premium credit of $0.29 would be kept by the premium seller. The risk of $4.71 would be incurred if the stock dropped below the $55.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Express Scripts is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Express Scripts is bullish.
The RSI indicator is at 65.22 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Express Scripts
Bye, Bye Co-Pay Cards? Why Express Scripts Is Excluding Dozens Of Drugs
Mon, 21 Oct 2013 18:10:00 GMT
Forbes – For the first time, Express Scripts has excluded a few dozen medicines from its national preferred formulary. The move, which the pharmacy benefits manager says will begin in January had been signaled to drugmakers, comes in the wake of rising prices for brand-name medications and, in particular, greater use of co-pay cards
Perfect time to buy stocks?
Fri, 18 Oct 2013 17:04:00 GMT
CNBC – “Strong fundamentals, reasonable valuations, and an accommodative central bank” cause the perfect combination to buy stocks says Katie Nixon, Northern Trust.
Express Scripts Stock No Prescription For Gains
Thu, 17 Oct 2013 16:16:00 GMT
Forbes – Morningstar has a bullish opinion on ESRX as detailed in this article and calculates a fair value of $89 per share for the stock. It seems to me that Morningstar’s research overlooks details in the financial footnotes or, worse, does not incorporate them into their analysis. I cannot be sure. Relying on reported […]
Sneak Peek: The Pros Hate These 5 Stocks — Should You?
Wed, 16 Oct 2013 15:20:00 GMT
TheStreet – BALTIMORE ( Stockpickr ) — Want to know what the “smart money” is thinking before your next trade? Just take a closer look at the stocks they hate. >> Why I'm Sticking By Dow 55,000 Professional …
Why UnitedHealth Earnings Won't Rely on Obamacare's Success
Wed, 16 Oct 2013 05:33:46 GMT
Motley Fool – Unlike rival WellPoint, UnitedHealth Group isn't making a big bet on health-insurance exchanges. Instead, it's looking to win no matter what happens with the Patient Protection and Affordable Care Act….
Also on Market Tamer…
Follow Us on Facebook